Skip to main content
. 2022 May 31;10(3):e02642-21. doi: 10.1128/spectrum.02642-21

TABLE 2.

Performance of DPP Syphilis Screen & Confirm with visual operator inspection and microreader analysis (cutoff of 9.0) according to HIV infection status

Assay and detection method No. of samples with:
Agreement (95% CI) (%) Sensitivity (95% CI) (%) Specificity (95% CI) (%) Kappa coefficient (95% CI)
True-positive results True-negative results
HIV-1 positivea
 Chembio treponemal componentb n = 165 n = 39
  Operator reading 138 39 86.7 (82.0–91.4) 83.6 (77.1–88.9) 100.0 (91.0–100.0) 0.66 (0.55–0.77)
  Microreader 134 39 84.8 (79.8–89.7) 81.2 (74.4–86.9) 100.0 (91.9–100.0) 0.62 (0.51–0.73)
 Chembio nontreponemal componentb n = 132 n = 72
  Operator reading 100 63 79.9 (74.3–85.4) 75.8 (67.5–82.8) 87.5 (77.6–94.1) 0.58 (0.47–0.69)
  Microreader 96 63 77.9 (72.2–83.6) 72.7 (64.3–80.1) 87.5 (77.6–94.1) 0.55 (0.44–0.66)
HIV-1 negative
 Chembio treponemal componentb n = 139 n = 40
  Operator reading 123 40 91.0 (86.8–95.2) 88.5 (82.0–93.3) 100.0 (91.2–100.0) 0.77 (0.67–0.87)
  Microreader 119 40 88.8 (84.1–93.4) 85.6 (78.7–91.0) 100.0 (91.2–100.0) 0.72 (0.61–0.83)
 Chembio nontreponemal componentb n = 110 n = 69
  Operator reading 67 62 72.0 (65.4–78.7) 60.9 (51.1–70.1) 89.9 (80.2–95.8) 0.46 (0.34–0.58)
  Microreader 63 63 70.3 (63.6–77.1) 57.3 (47.5–66.7) 91.3 (82.0–96.7) 0.43 (0.32–0.55)
a

The HIV-1 confirmatory test was Western blotting.

b

Reference tests were the TPPA test for treponemal antibodies and the RPR test for nontreponemal antibodies.